Skip to content

mbeck

Eight more NMIN Advanced Training Certification (ATC) recipients announced

The NanoMedicines Innovation Network (NMIN) is pleased to announce eight new recipients of NMIN Advanced Training Certification (ATC). NMIN’s Advanced Training Certification, or ATC, recognizes an individual’s engagement in diverse capacity-building activities offered by NMIN, its partners, and other recognized organizations, where the learning involved goes “above and beyond” the… Read More »Eight more NMIN Advanced Training Certification (ATC) recipients announced

NMIN Board of Directors names Dr. Gilbert Walker Scientific Director & CEO

The Board of Directors of the NanoMedicines Innovation Network (NMIN), a national Networks of Centres of Excellence (NCE) funded by the Government of Canada, has appointed Dr. Gilbert Walker Scientific Director & CEO, effective 14 September 2022. Dr. Walker is a Distinguished Professor in the Department of Chemistry in the… Read More »NMIN Board of Directors names Dr. Gilbert Walker Scientific Director & CEO

Pieter Cullis to receive Global Impact Award from Life Sciences BC

Dr. Pieter Cullis continues to accumulate accolades for his life’s work developing liposomal-based technologies as the basis for novel therapeutic approaches to diagnosing, treating, and curing disease. An additional recognition, “for his scientific entrepreneurialism and advancement of life sciences research,” is coming in the form of the Global Impact Award… Read More »Pieter Cullis to receive Global Impact Award from Life Sciences BC

NMIN start-up SeraGene wins Amgen-sponsored incubation support

The start-up company SeraGene, spun out of NMIN and co-founded by NMIN research co-leader Dr. Christian Kastrup (UBC), NMIN HQP Amy Wong-Strilchuk, and NMIN’s Founding Scientific Director, Dr. Pieter Cullis, has received a 2022 “Amgen Golden Ticket” at the UBC-based SBME Innovates incubation hub. UBC’s School of Biomedical Engineering (SBME)… Read More »NMIN start-up SeraGene wins Amgen-sponsored incubation support

Dr. Pieter Cullis & colleagues awarded 2022 Tang Prize

For their contributions to the development of an mRNA-based COVID vaccine, NMIN’s Founding Scientific Director, Dr. Pieter Cullis (UBC), together with his colleagues Drs Katalin Karikó (University of Szeged) and Drew Weissman (University of Pennsylvania), have been jointly awarded the 2022 Tang Prize in in Biopharmaceutical Science. The prize recognizes… Read More »Dr. Pieter Cullis & colleagues awarded 2022 Tang Prize

Canadian nanomedicines in the spotlight: Molecular Pharmaceutics

A new special issue of the American Chemical Society journal Molecular Pharmaceutics highlights outstanding work related to contemporary nanomedicine research in Canada. The issue, “Tiny Things, Huge Impact: Nanomedicine in Canada,”  was edited by NMIN researchers Dr. Shyh-Dar Li, Ellen Wasan, Marcel Bally, and Sarah Hedtrich, who contribute an editorial summarizing the… Read More »Canadian nanomedicines in the spotlight: Molecular Pharmaceutics